| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.07 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.3 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.28 | 0.3 |